Lupin receives tentative USFDA approval for Fosaprepitant for Injection
The company can now market a generic version of Merck's Emend for Injection, 150 mg Single-Dose Vial
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Yasir Rawjee appointed as CEO of Glenmark Life Sciences
Rawjee, who will now head the company's newly created API unit, was previously Head of Global API Operations at Mylan Inc
Hester Biosciences recommends a final dividend of INR 7 per share
The company declared its consolidated financial report, registering a 44 per cent hike in profit margins for FY19
Unichem Labs gets USFDA tentative nod for allergic rhinitis drug
The company got the US health regulator's nod for its Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride extended-release…
Merck Limited renamed as Procter & Gamble Health Limited
New name reflects new identity of the listed entity as part of the P&G Group
Vivimed recalls hypertensive drug from US market due to impurities
According to the USFDA, the drug, Losartan Potassium Tablet, could put certain patients under a heightened risk of developing…
Morepen Labs’ Q4 net profit up by 54 per cent at Rs 10.49 crore
The company declared that with the latest surge in profits, it has now officially become debt free
Medlife acquires medicine delivery startup Myra Medicines
While Myra was earlier handling about 4,000 deliveries a day in Bengaluru, its services are now ready to be scaled across 22…
Dr. Reddy’s Lab launches Testosterone Gel, 1.62% in the US
The drug company has received USFDA's approval to sell Testosterone Gel, 1.62%, which is a generic version of AndroGel
NPPA fixes retail prices for 20 formulations, revises for 2
The changes have been made under the Drugs Prices Control Order (DPCO), 2013